Therefore, the specific effect of hyperlipidaemia on plasma apoM in patients with T2DM should be investigated to confirm whether low plasma apoM levels in T2DM are caused by diabetes or hyperlipidaemia. The gene discussed is APOM; the disease is diabetes mellitus.